Creation
Draft
Initial
Detailed
Signpost/Archive
Idea Description
Supplementary Information
Detailed Submission Data
Innovation 'Elevator Pitch':
OurPath is a 3-month online programme to help you build healthier habits and reduce your risk of Type 2 diabetes. We provide: health-tracking technology, personalised health coaching from a dietician and evidence-based structured education.
Overview of Innovation:


The health needs of the UK population are changing and the way we interact with healthcare is evolving. Nationally, the internet is being used to manage our lives, changing the way we shop, bank, watch TV and communicate. The west midlands has one of the highest rates of diabetes and pre-diabetes in the country. Many of these people may benefit from digital services that may help them manage their lifestyles, preventing them from moving into higher risk stratification levels which would ultimately require increased GP time to manage.
OurPath provide a 12 week behavioural change programme for people at risk of, or already living with type 2 diabetes. The programme helps people to change their behaviours for the long term, and improve their health outcomes. The programme delivers:

• Evidence-based structured education on nutrition, exercise, sleep, stress management, and positive psychology
• Peer group support (an online group of 10 others similar to the user)
• Personalised health coaching from a registered dietitian
• Tracking technology (smart weighing scales and a wearable activity tracker).

The programme is already being trialled as part of NHS England's digital diabetes prevention programme and across the extremely diverse area of 6 CCG's in North West London. Following positive outcomes data and feedback from the NWL team, we are looking to open up OurPath to the rest of the country.
We are proposing a pilot project to deliver the OurPath programme to 500 people at risk of developing type 2 diabetes in the west midlands. The project will demonstrate the outcomes of the OurPath programme in the local population in order to enable future widespread commissioning.

1-minute introduction to OurPath video: https://vimeo.com/199648301

www.ourpath.co.uk

Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
Similar Content5
Innovation 'Elevator Pitch':
Liva helps people prevent and reverse chronic diseases and manage lifestyle challenges by scaling meaningful human relationships using technology. At the same time, Liva drives efficiency and reduces costs for healthcare providers and payers
Overview of Innovation:
Liva Healthcare is a proven solution provider for NHS England, Healthier you, Digital Diabetes Prevention Programme pilot. 
  • An advanced yet intuitive digital platform fully approved for use with the NHS (a service user app (front end), and a dashboard command (backend) for health coaches)
  • A patient centric approach in platform and programme design
  • An expert coaching team with significant experience in impacting lifestyle change
  • Individualised coaching services delivered predominantly digitally, but with a differentiating, relationship-building face-to-face Initial Assessment.
  • A structured education approach encompassing a modulated library of content with individualised lifestyle advise, provided by a leading general practitioner in diabetes management.
  • An evidence-based and approach to behaviour change and diabetes management.
  • Strongly governed clinically by frameworks and evidence-based care pathways. 
  • A proven and effective team of experts who ensure optimal standards of implementation.
  • An attractive solution that is economically sustainable with staged fee structures linked to continued engagement.
  • Clinically proven, with users maintaining 7kg of weight loss after 20 months and €2,000+ savings in societal costs per year per diabetic. 
  • Scalable and efficent with more patients to be handled with less resources. 
Liva has achieved success through refining and adjusting the programme based on clinical evidence, coach feedback and patient evaluation.  We base the programme and all of its interventions on the acknowledgement of the reality of people’s lives, working on their terms, not ours.
  • Liva’s design philosophy is about intuitive solutions, easy to understand and use, even for non-digital natives.
  • It offers access across all popular platforms such as iOS and Android in addition to any computer or tablet. It has been particularly important for us to design with lower socio-economic groups in mind so - for example - dietary tracking can be done via simple photographs of meals rather than calorie counting. The same intelligence applies to the option of sending video messages as an alternative to text options in order to lower a barrier for usage.
  • Liva has established protocols to deliver appropriate levels of intervention based on need with specific emphasis around fluid, rolling engagement monitoring and to help service users get back on track and recover their progress if newly developed behaviours are disturbed. 
To find our more please visit: www.livahealthcare.com
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Wellness and prevention of illness / Clinical trials and evidence / Digital health / Innovation and adoption
Benefit to NHS:
Tackling chronic diseases
Liva Healthcare tackles chronic lifestyle diseases such as Type 2 diabetes, obesity and heart disease by connecting patients with a personal health coach through an app to track and monitor the patient’s health goals. The app is based on strong evidence that has shown lifestyle interventions, delivered digitally, can lead to long-term lifestyle change. These changes can prevent the onset, and even reverse the diagnosis, of lifestyle diseases such as Type 2 diabetes.
 
Digital innovation for the NHS
Liva Healthcare helps NHS prevent Type 2 diabetes. The NHS chose Liva as a provider for the pilot of the digital stream of its Healthier You: NHS Diabetes Prevention Programme, whereby GPs can refer patients at risk of developing Type 2 diabetes to use the Liva app. Patients using this service have already been reporting weight loss of up to 14Ibs in weight in under 8 weeks, improved health and some are no longer pre-diabetic! 

Driving change through the power of relationships 
Liva Healthcare's innovative platform has been built with both patients and healthcare professionals in mind. For digital health to be effective, research has shown algorithms aren’t enough. Liva Healthcare’s service is built on the evidence that creating close relationships between healthcare professionals and their patients can lead to long-lasting behaviour and lifestyle change. Liva Healthcare’s technology therefore facilitates healthcare professionals in doing their jobs, rather than aiming to replace them.
 
Driving efficiency and patient outcomes
Liva Healthcare can demonstrate fantastic real-world results for patients and healthcare services.
  1. Liva Healthcare’s platform enables more patients to be handled with less resources. Using the Liva Healthcare service, health professionals are able to work with up to 400 patients without impacting patient outcomes.
  2. On the Liva programme, clinical research found Liva users maintained 7kg of weight loss after 20 months.
  3. The Liva Healthcare solution has been found to create €2,000+ savings in societal costs per year per diabetic.
Liva offers a turn-key solution with a flexible deployment approach adaptable to local CCG needs and requirements. 
 
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
The convenience of digital and powerful tech combined with the motivating power of frequent human-to-human interaction​.

Critical Success Factors in preventing Type II Diabetes

Patient-centric thinking to deliver accessible technology and expertise
It is in the experience of Liva that changing behaviour requires a patient-centric approach, hence why we have made this the primary goal of both the coaching platform and service user programme including the app. We find it of crucial importance to: -
 
  • Establish a relationship of trust and empathy between service user and health coach
  • Set realistic goals
  • Support continuous motivation
  • Provide supporting education
  • Ensure that all touch-points between service user and health coach are as simple and intuitive as possible. 
Liva has achieved success through refining and adjusting the programme based on clinical evidence, coach feedback and patient evaluation.  We base the programme and all of its interventions on the acknowledgement of the reality of people’s lives, working on their terms, not ours.
  • Liva’s design philosophy is about intuitive solutions, easy to understand and use, even for non-digital natives.
  • It offers access across all popular platforms such as iOS and Android in addition to any computer or tablet.
  • It has been particularly important for us to design with lower socio-economic groups in mind so - for example - dietary tracking can be done via simple photographs of meals rather than calorie counting. The same intelligence applies to the option of sending video messages as an alternative to text options in order to lower a barrier for usage.
  • The programme can be made available in any language for a diverse population wherey English isn't necessarily their first language
  • Highly trained lifestyle coaches are recruited to match the demographic area being served.
  • Liva has established protocols to deliver appropriate levels of intervention based on need with specific emphasis around fluid, rolling engagement monitoring and to help service users get back on track and recover their progress if newly developed behaviours are disturbed. 
Current and planned activity: 
Liva Healthcare - over the course of 16 years - has provided more than 140,000 service users individualised programmes for sustained, lifestyle improvement. Since July 2016, Liva Healthcare has established a UK presence, and formed an operational, nationwide network of health coaches with extensive experience of digitally-delivered behaviour-change techniques. In addition, Liva Healthcare is a proven solution provider for NHS England, Healthier you, Digital Diabetes Prevention Programme pilot. Currently bidding with face to face partners for the National Diabetes Preventon Pilot and continues to provide the lIva 
What is the intellectual property status of your innovation?:
Liva Healthcare has complete ownership and proprietary use of all:  
  • Technology 
  • Content
  • Evidence of cliincal outcomes in assocations with leading institutions.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Read more
Hide details
Innovation 'Elevator Pitch':
Changing Health address signficant barriers to access by providing X-PERT diabetes education on line together with personalised evidence based telephone coaching to enable sustained behaviour change leading to improved clinical outcomes.
Overview of Innovation:

Changing Health offers the 1st evidence based digital education and personalised support programme for people living with Type 2 diabetes. Our digital diabetes prevention programme is currently under evaluation by Public Health England to be launched in September.

Our high quality service is based on evidence gathered from research led by Prof. Michael Trenell’s team at Newcastle University and the Newcastle Hospitals NHS Foundation Trust, conducted over 8 years and funded largely by the NIHR and MRC. This background has been licenced to Changing Health and combined with other state of the art structured education.

The service has been reviewed by NHS England Right Care, Public Health England, as well as other national stakeholders. Furthermore, it has undergone cluster based control trial, reviewed by NHS England and NICE, and submitted to be included in the first wave of approvals for mobile digital services.  Exclusive instant online access to X-PERT, the only Type 2 diabetes education programme proven to have clinically meaningful impact on weight and glycaemic control, together with ongoing learning via a referenced knowledge base. Re-designed for delivery through mobile and web apps, content is delivered in a variety of formats - including cartoon animations, interactive exercises and article text - supported by a personal coach.

Key features:
  • Evidence based behaviour change tools, including: the ability to create goals, make specific plans and self-monitor by tracking physical activity directly from the phone, record food intake, weight and other important data.
  • Communication with a personally assigned coach trained in evidence based behaviour change techniques, with the ability to book coaching sessions over the phone.
  • Online education modules in behaviour change for healthcare professionals, accredited by the Royal College of Physicians, equipping them with evidence based tools to help their patients better self manage. These modules are designed to be used alongside the aforementioned patient-facing tools, enabling HCPs to hold informed dialogue.
Recognising important cultural and linguistic diversity, Changing Health has collaborated with the South Asian Health Foundation and Diabetes UK to make services available in English, Punjabi, Gujarati (Bengali/Urdu dialects) and Polish languages.

The service is offered by the Modality Vanguard and is ready for wider adoption.



Evidence & Research
https://www.changinghealth.com/evidence.html
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Type 2 diabetes is characterised by progressive weight gain, driving the worsening of glycemic control. Changing Health directly targets this by providing evidence based weight management services through a digital platform. Excess weight is the greatest factor influencing the development of Type 2 diabetes, with over 80% of people overweight or obese. In the first five years post-diagnosis, a person with type 2 diabetes has a twofold increase in their risk of a stroke. They also have an ongoing risk of CVD twice that of a person without diabetes - and CVD is responsible for 52% of deaths in people with Type 2.

Changing Health’s service creates value for money by:
  • Delivering better health outcomes: Audit results demonstrate that X-PERT provides a sustained reduction in HbA1c (-6mmol.mol) and weight (-4.4kg).
  • Reducing spend: Over the first 6 months, X-PERT has been shown to generate an 8.3% reduction in prescribing costs equating to average savings in prescribing costs at £131,052 per 1,000 people attending, per year.
  • Improving care quality: Reducing variation in care through a standardised and proven approach, coupled with personalised coaching.
  • Opening access: Reducing barriers to access by making our services available anytime, anywhere, in English as well as the five most prevalent foreign languages.
  • Engaging patients in self-care: Providing patients with the education and tools to self manage their diabetes.
  • Supporting commissioning: Tracking outcomes easily and efficiently.
  • Providing the opportunity for effective investment of resources.
  • Supporting care teams: Providing evidence based online education modules, and freeing up healthcare professional time - such as enabling DSNs currently providing education to provide care and support to colleagues as well as patients.
  • Helping people early with their diabetes: The younger someone is diagnosed with diabetes, the greater their lifetime cost of their condition. This younger group are also more likely to access digital tools, creating an optimal method of engagement.
Online Discussion Rating
5.00 (1 ratings)
Initial Review Rating
5.00 (2 ratings)
Benefit to WM population:
Public Health England estimate that there are 433,000 people with Type 2 diabetes in the West Midlands.

At current levels of attendance for education, there is a substantial unmet need addressed by our services for people with Type 2 diabetes. Today there is little, if any, coaching support to empower people to achieve the changes in behavious which are proven to improve outcomes. Changing Health offers the facility to address this need by substantially improving access: it has the capacity to do so across the West Midlands region.

Changing Health addresses signficant barriers to access of supported self management for patients with Type 2 diabetes, making information and evidenced based support available anytime and anywhere and in 6 languages, including 5 South Asian Languages (2 Bengali dialects, Punjabi, Gujarati and Urdu) and Polish. These will be phased in during the 4th quarter of 2017.

Changing Health is currently being used in Birmingham in conjunction with the Modality Vangaurd, working with the Connected Care Partnership https://modalitypartnership.nhs.uk
 
Current and planned activity: 
Changing Health's innovative service is currently deployed in 7 georgraphies including West and East London, Birmingham and Manchester.

Our prevention service is currently being evaluated by Public Health England and is expected to be deployed in September 2017.
What is the intellectual property status of your innovation?:
The intellectual property of our behaviour change techniqes has been licenced exclusively to Changing Health by the NIHR and MRC.

X-PERT Health has exclusively licenced its programme to Changing Health to be made available in a digital format accessbile via a mobile, tablet or computer.  
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Regional Scalability:
Our ability to scale has been recently & satisfactorily tested by Public Health England. The digital elements of our service are designed for scale. We have capacity to provide personalised coaching services for up to 500,000 people.
 
Public Health England estimates 433,000 people with Type 2 diabetes in the West Midlands. At current levels of attendance of education, there is a substantial unmet need addressed by our services for people with Type 2 diabetes. Today, there is little if any coaching support to empower people to achieve the changes in behaviour which are proven to improve outcomes. Changing Health offers the facility to address this need by substantially improving access: it has the capacity to do so across the West Midlands. 
 
Together with Diabetes UK & the South Asian Health Foundation we are currently translating our modules into 5 South Asian Languages: 2 Bengali dialects, Punjabi, Gujarati & Urdu as well as Polish. These will be phased in during 4th quarter 2017
Measures:
Changing Health would report process and output measures:
  • Referrals received
  • Patients enrolling
  • Patients completing
  • Complaints received/resolved
  • Patients empowerment scores
  • Patient experience questionnaires
For people with Type 2 Diabetes would like clinicians to gather and report:
Weight and Hba1c at referral, after 6 months and 12 months.
 
The X-PERT reporting processes include other metrics including cholesterol and blood pressure. We’d welcome this being reported too.
 
The metrics for the Diabetes Prevention Programme are being developed by Public Health England. A substantial data set is already in place for the face to face programme. The digital dataset is yet to be determined. 
Adoption target:
433,000 people with Type 2 in WM. NICE/NHSE/DUK all advocate education and support with parliament stating that CCGs should plan for radical expansion and improved access.  The unmet need is substantial. As a digital and telephone service we can operate at scale. Capacity is likely to be set by the funding available.
 
Min level is 250 people per CCG
Read more
Hide details
Innovation 'Elevator Pitch':
Oviva Diabetes Support and Prevention are QISMET-accredited education and behavioural change interventions for people with or at risk of type 2 diabetes, which have demonstrated signficant improvements in uptake and clinical outcomes.
Overview of Innovation:
Oviva’s services for people with or at risk of type 2 diabetes are now available in 18 CCGs across England, and have demonstrated improved uptake and outcomes in comparison with traditional models of care. 

Oviva services offer accessible, evidence-based, personalised care 
All Oviva services combine:
  • High-frequency, 1-to-1 coaching from a diabetes specialist dietitian to drive behaviour change and tackle psychological barriers, delivered over the telephone or using the Oviva app.
  • Supporting materials for participants to access in their own time, including videos, podcasts, and written guides, which explain more about type 2 diabetes. Participants retain access to resources for life, and they are available online or as hard copy booklet and/or DVD. All Oviva resources reflect NICE and NHS guidelines and are reviewed by a clinical advisory board regularly.
  • Optional use of the Oviva smartphone app, which participants can use to maintain a food diary and access learning resources. This app links to the dietitian’s electronic patient record to enable the dietitian to provide feedback. 
  • Activation call from Oviva patient pathway coordinators, who are trained in motivational interviewing and focused on driving uptake.
This approach is tailored to meet the needs of different patient cohorts, as described below. 

Oviva Diabetes Prevention: an 8 week intensive education and behaviour change programme with follow up care at 3, 6 and 12 months, focused on weight loss and reducing HbA1c levels (for patients with non-diabetic hyperglycaemia). This service has recently been adopted as part of the NHS Diabetes Prevention Programme in England, and real world data will be available for analysis soon.

Oviva Diabetes Support: an 8 - 10 week QISMET-accredited structured education and behaviour change programme, focused on supporting patients to meet diabetes treatment targets, lose weight, and develop sustainable self-management skills. Real world data demonstrates an average HbA1c reduction of 13mmol/mol at 6 months, weight loss of -4.5%, whilst patients report that their average confidence in managing their diabetes increased from 4/10 to 8/10 (clinical outcomes from 85 patients). Uptake in 1453 referrals is c.70%, compared with c.30% in traditional models. 

Oviva Diabetes Support has now been selected by NHS England to join the NHS Innovation Accelerator and the Digital Diabetes Coach Test Bed. 

To view our Information Pack - click here.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Oviva Diabetes Support and Prevention benefit the NHS by widening access to effective care, and generating improved patient outcomes for people with or at risk of type 2 diabetes. In turn, this drives efficiency savings in terms of avoiding preventable utilisation of services in primary and secondary care, along with medications and treatment costs associated with disease progression and diabetes complications. 

As described in the overview, service uptake is c.71%. By contrast, the National Diabetes Audit indicates that uptake of structured education for people newly diagnosed with type 2 diabetes is c.7.4% (2.9% in the West Midlands), and uptake of the National Diabetes Prevention Programme is 49%. Increased accessibility and flexibility enables people unable or unwilling to access traditional face-to-face courses, along with supporting commissioners and clinicians to meet targets associated with attendance at diabetes structured education included in the NHS Improvement and Assessment Framework and Quality and Outcomes Framework.

Moreover, real world data (85 Oviva Diabetes Support patients) demonstates an average HbA1c reduction at c.6 months of 13mmol/mol, and bodyweight loss of 4.5%, supporting the achievement of diabetes treatment targets (also included in the Improvement and Assessment Framework and Quality and Outcomes Framework). 

These clinical outcomes can drive a return on investment for CCGs; Frontier Economics modelling indicates that based on existing clinical outcome data, provision of Oviva Diabetes Support for 500 participants achieves £219k of year 1 savings, rising to £550k by year 5. This is comprised of avoidance of 72 admissions, 100 outpatient and 280 GP visits, along with avoidance of more than £17k of prescribing costs. Targeting the service at patients receiving or likely to need high cost medications (including insulin, SGLT-2, and GLP-1) could drive additional savings of more than £800 per participant per year. 

Oviva Diabetes Support and Prevention also offer commissioners a 'payment by engagement' cost model, ensuring that commissioners only fund the service for active participants. This contrasts with the block contract model of traditional face-to-face group courses, which offers commissioners limited recourse to challenge poor uptake locally.  
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
By providing an accessible, flexible and effective approach to improving outcomes for people with type 2 diabetes Oviva Diabetes Support and Prevention can impact on the WM population (7.7% of whom have type 2 diabetes, and 11% of whom are likely to be at risk) beyond the local health economy by:
  • Reducing the need for people with or at risk of type 2 diabetes requiring time away from work to attend education courses or future appointments associated with the treatment of complications, thus contributing to maintaining productivity and the local economy.
  • Providing participants with personalised and remote care widens access to cohorts identified as less likely to attend traditional programmes, such as working age men, BME groups, or rural communities, particularly essential in diverse populations such as the West Midlands. Evidence of accessibility can be seen in the success of Oviva Diabetes Support in areas such as London and Devon.   
  • Reducing the impact on the environment associated with delivery of traditional models of care, which drives a number of journeys for patients and staff and the environmental costs associated with physical premises.
  • Improving outcomes enables people with type 2 diabetes to remain in work; Diabetes UK has estimated that the costs of reduced productivity at work due to people with diabetes not working because of death or poor health, or working at a lower level of productivity are estimated at nearly £9 billion.  
Current and planned activity: 
Oviva Diabetes Support is currently in pilot or commissioned in the following areas: North West London collaborative of CCGs, South West London collaborative, NEW Devon CCG, Chiltern and Aylesbury Vale CCGs, Swindon CCG, Somerset CCG, Leicester, Leicestershire and Rutland CCGs, and Salford CCG. Oviva Diabetes Support will soon be available to self-referral nationally as part of the Diabetes Digital Coach Test Bed. Oviva Diabetes Support is supported through NHS England through the NHS Innovation Accelerator, and has been rewarded a research grant via Innovate UK and the digital health catalyst to evaluate our clinical outcomes with King's College London. 

Oviva Diabetes Prevention is part of the NHS England Healthier You - Diabetes Prevention Programme digital stream, recently launching in North West London, Somerset, and Chiltern and Aylesbury Vale CCGs. 

Oviva is keen to explore opportunities for adoption of our service in the West Midlands. 
What is the intellectual property status of your innovation?:
All intellectual property is owned by Oviva. 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Read more
Hide details
Innovation 'Elevator Pitch':
Oviva Diabetes Support and Prevention are QISMET-accredited education and behavioural change interventions for people with or at risk of type 2 diabetes, which have demonstrated signficant improvements in uptake and clinical outcomes.
Overview of Innovation:
Oviva’s services for people with or at risk of type 2 diabetes are now available in 18 CCGs across England, and have demonstrated improved uptake and outcomes in comparison with traditional models of care.

Oviva services offer accessible, evidence-based, personalised care
All Oviva services combine:
  • High-frequency, 1-to-1 coaching from a diabetes specialist dietitian to drive behaviour change and tackle psychological barriers, delivered over the telephone or using the Oviva app.
  • Supporting materials for participants to access in their own time, including videos, podcasts, and written guides, which explain more about type 2 diabetes. Participants retain access to resources for life, and they are available online or as hard copy booklet and/or DVD. All Oviva resources reflect NICE and NHS guidelines and are reviewed by a clinical advisory board regularly.
  • Optional use of the Oviva smartphone app, which participants can use to maintain a food diary and access learning resources. This app links to the dietitian’s electronic patient record to enable the dietitian to provide feedback.
  • Activation call from Oviva patient pathway coordinators, who are trained in motivational interviewing and focused on driving uptake.
This approach is tailored to meet the needs of different patient cohorts, as described below.

Oviva Diabetes Prevention: an 8 week intensive education and behaviour change programme with follow up care at 3, 6 and 12 months, focused on weight loss and reducing HbA1c levels (for patients with non-diabetic hyperglycaemia). This service has recently been adopted as part of the NHS Diabetes Prevention Programme in England, and real world data will be available for analysis soon.

Oviva Diabetes Support: an 8 - 10 week QISMET-accredited structured education and behaviour change programme, focused on supporting patients to meet diabetes treatment targets, lose weight, and develop sustainable self-management skills. Real world data demonstrates an average HbA1c reduction of 13mmol/mol at 6 months, weight loss of -4.5%, whilst patients report that their average confidence in managing their diabetes increased from 4/10 to 8/10 (clinical outcomes from 85 patients). Uptake in 1453 referrals is c.70%, compared with c.30% in traditional models.

Oviva Diabetes Support has now been selected by NHS England to join the NHS Innovation Accelerator and the Digital Diabetes Coach Test Bed.

To view our Information Pack - click here.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach
Benefit to NHS:
Oviva Diabetes Support and Prevention benefit the NHS by widening access to effective care, and generating improved patient outcomes for people with or at risk of type 2 diabetes. In turn, this drives efficiency savings in terms of avoiding preventable utilisation of services in primary and secondary care, along with medications and treatment costs associated with disease progression and diabetes complications.

As described in the overview, service uptake is c.71%. By contrast, the National Diabetes Audit indicates that uptake of structured education for people newly diagnosed with type 2 diabetes is c.7.4% (2.9% in the West Midlands), and uptake of the National Diabetes Prevention Programme is 49%. Increased accessibility and flexibility enables people unable or unwilling to access traditional face-to-face courses, along with supporting commissioners and clinicians to meet targets associated with attendance at diabetes structured education included in the NHS Improvement and Assessment Framework and Quality and Outcomes Framework.

Moreover, real world data (85 Oviva Diabetes Support patients) demonstates an average HbA1c reduction at c.6 months of 13mmol/mol, and bodyweight loss of 4.5%, supporting the achievement of diabetes treatment targets (also included in the Improvement and Assessment Framework and Quality and Outcomes Framework).

These clinical outcomes can drive a return on investment for CCGs; Frontier Economics modelling indicates that based on existing clinical outcome data, provision of Oviva Diabetes Support for 500 participants achieves £219k of year 1 savings, rising to £550k by year 5. This is comprised of avoidance of 72 admissions, 100 outpatient and 280 GP visits, along with avoidance of more than £17k of prescribing costs. Targeting the service at patients receiving or likely to need high cost medications (including insulin, SGLT-2, and GLP-1) could drive additional savings of more than £800 per participant per year.

Oviva Diabetes Support and Prevention also offer commissioners a 'payment by engagement' cost model, ensuring that commissioners only fund the service for active participants. This contrasts with the block contract model of traditional face-to-face group courses, which offers commissioners limited recourse to challenge poor uptake locally.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
By providing an accessible, flexible and effective approach to improving outcomes for people with type 2 diabetes Oviva Diabetes Support and Prevention can impact on the WM population (7.7% of whom have type 2 diabetes, and 11% of whom are likely to be at risk) beyond the local health economy by:
  • Reducing the need for people with or at risk of type 2 diabetes requiring time away from work to attend education courses or future appointments associated with the treatment of complications, thus contributing to maintaining productivity and the local economy.
  • Providing participants with personalised and remote care widens access to cohorts identified as less likely to attend traditional programmes, such as working age men, BME groups, or rural communities, particularly essential in diverse populations such as the West Midlands. Evidence of accessibility can be seen in the success of Oviva Diabetes Support in areas such as London and Devon.
  • Reducing the impact on the environment associated with delivery of traditional models of care, which drives a number of journeys for patients and staff and the environmental costs associated with physical premises.
  • Improving outcomes enables people with type 2 diabetes to remain in work; Diabetes UK has estimated that the costs of reduced productivity at work due to people with diabetes not working because of death or poor health, or working at a lower level of productivity are estimated at nearly £9 billion.
Current and planned activity: 
Oviva Diabetes Support is currently in pilot or commissioned in the following areas: North West London collaborative of CCGs, South West London collaborative, NEW Devon CCG, Chiltern and Aylesbury Vale CCGs, Swindon CCG, Somerset CCG, Leicester, Leicestershire and Rutland CCGs, and Salford CCG. Oviva Diabetes Support will soon be available to self-referral nationally as part of the Diabetes Digital Coach Test Bed. Oviva Diabetes Support is supported through NHS England through the NHS Innovation Accelerator, and has been rewarded a research grant via Innovate UK and the digital health catalyst to evaluate our clinical outcomes with King's College London.

Oviva Diabetes Prevention is part of the NHS England Healthier You - Diabetes Prevention Programme digital stream, recently launching in North West London, Somerset, and Chiltern and Aylesbury Vale CCGs.

Oviva is keen to explore opportunities for adoption of our service in the West Midlands.
What is the intellectual property status of your innovation?:
All intellectual property is owned by Oviva.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Read more
Hide details
Innovation 'Elevator Pitch':
The Sound Doctor is the leading source of film and audio patient information in the UK, offering a coherent and authoritative learning programme encouraging effective self-management of diabetes.
Overview of Innovation:
The Sound Doctor's unique self-management library includes 60 short films covering all aspects of living with diabetes. The material is of exceptionally high quality and offers a structured programme of education, which can be a lifelong companion for people living with the condition. 

The aims of The Sound Doctor self-management programme are:
 
1. To reduce the number of avoidable admissions (and readmissions) to hospital
2. To reduce the need for face-to-face contact with clinicians (and to improve the quality of meetings which do take place)
3. To improve medicines management and compliance with medications
4. To improve the quality of care for patients (and patient experience of their care)
5. To help people get the most out of life through effective self-management

The diabetes library
Developed after consultation with Diabetes UK, leading clinicians and patient groups, the films offer detailed and practical advice about diet, activity, medicines, blood glucose monitoring and many other aspects of living with diabetes. The material is motivational, positive and reassuring. We include interviews from healthcare professionals that people will come across in the course of their journey, including consultants, GPs, podiatrists, dietitians, psychologists, specialist nurses, pharmacists and Diabetes UK. There is also reassuring advice from people living with diabetes about taking day-to-day control.

Your healthcare team in your pocket, available 24/7. The advice you need when you want it.

The films specifically address the causes of diabetes, the long and short-term complications and risks and more than half of the films detail steps that people can take to take ownership of the condition, improve their lifestyle and reduce the risks of complications. A list of content is available.

The Sound Doctor has a proven and demonstrable role in improving self-management, and has been exceptionally well received by patients.

The films are extremely well reviewed by healthcare professionals and other experts and, in evaluations, users overwhelmingly report increased knowledge and confidence as well as fewer visits to the GP and fewer hospital admissions. We have evidence that people change their attitudes and behaviour towards diet and exercise. We also know that the films improve people’s satisfaction with, and experience of, their care.
The Sound Doctor is currently being used in a number of CCGs and Hospital Trusts around the country as well as community pharmacies.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Person centred care
Benefit to NHS:
Diabetes costs the NHS £10bn every year – mainly due to complications which can be avoided or delayed through effective education. People with diabetes are more likely to be admitted to hospital and have longer stays.
 
Those with diabetes may see their healthcare team only once or twice a year so effective self-management driven by effective information is essential.
 
The Sound Doctor library is not an ad hoc series of films touching on a few subjects that might be of interest to someone with diabetes. It is a comprehensive, structured education programme that can be a companion for life.
 
An evaluation carried out in West Leicestershire in December 2016 among long-term users of The Sound Doctor found:
 
96% of users understood their condition better
98% learned new information about their condition
96% felt more confident about managing their condition effectively
88% had a better understanding of their medicines (10%not applicable)
93% have changed their self-management technique
98% found The Sound Doctor easy to use
99% found it a useful addition to their healthcare
 
Crucially:
 
92% of users reported fewer visits to their GP
62% said they had been to hospital less often
 
 
Why The Sound Doctor?
 
80% of the cost of diabetes is spent on complications. The Sound Doctor films aim to reduce the likelihood of developing complications by delivering effective advice on diet, activity, medicines management, blood glucose monitoring, HbA1c and other aspects of  self-management including specific films on looking after your feet and eyes that can directly reduce the likelihood of amputation and blindness. There are sixty films in all. 
 
Self-management is the key to reducing the costs of treating many long-term conditions in a testing financial climate. The Sound Doctor is a class-leading information product that can achieve this.
 
“The quality of the product is, in my experience, unmatched anywhere in the world.”
Dr Charles Alessi, Senior Adviser Public Health England
 
 ROI
 
Costs are reduced in various ways including GP appointments at an average cost of £25 and hospital admissions for foot ulcers and amputation, dialysis, cardiovascular disease, sight impairment and neuropathy. Other benefits are derived from decreasing the number of bed days in hospital and increasing attendance and productivity at work.

For more information please contact Rosie Runciman: rosie@thesounddoctor.org (Tel) 01285 850887
Website: www.thesounddoctor.org
Initial Review Rating
5.00 (2 ratings)
Benefit to WM population:
All the benefits outline above apply equally to the West Midlands population. This is a versatile and scalable product which has been adopted in several CCGs and hospital trusts around the UK. 

We are particularly keen to develop our product and produce new material for and in the West Midlands as a local company benefiting from the Serendip programme at iCentrum.
Current and planned activity: 
When funds permit, The sound Doctor intends to continue producing new libraries of films addressing other conditions. In particular we plan a comprehensive package of films covering stress, anxiety and depression; alcohol; further musculo-skeletal conditions and weight management.

We are open to discussion on co-producing further, localised material on diabetes to reflect the West Midlands population more accurately.
What is the intellectual property status of your innovation?:
The Sound Doctor owns all IP in all products. Material is generally licensed to clients on an annual or monthly basis (min 12 months) and allows access for up to 100,000 users
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Read more
Hide details

Created by

Share and Follow